42% of deaths in the world are due to some kind of fibrotic disease. Despite efforts over the last 50 years, there is still no cure.
Fibrosis occurs when the body produces too much scar tissue, doing more harm than good. It can affect any organ and can be deadly.
During the pandemic, interest in fibrotic disease has increased due to COVID-19 infections causing some patients to develop it in the lungs, hearts and kidneys.
Selim Cellek, biomedical researcher at Anglia Ruskin University, delves into why this disease is so difficult to find a treatment for, whether the focus should shift to prevention and the research going on right here in Chelmsford to shed light on this prevalent, but elusive disease.